Crystalline forms of an antiviral benzimidazole compound

摘要

The invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole, pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy.

主权项

1. A pharmaceutical composition comprising a crystalline form of Form I 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1Hbenzimidazole having substantially the same X-ray powder diffraction pattern as FIG. 1, wherein said X-ray diffraction pattern is obtained with a diffractometer equipped with a diffracted beam curved graphite monochromator and utilizing copper Kα X-radiation, and at least one pharmaceutically acceptable carrier therefor; with the proviso that the pharmaceutical composition is not a solution of the active ingredient.